Personalis (PSNL) Stock Forecast, Price Target & Predictions
PSNL Stock Forecast
Personalis stock forecast is as follows: an average price target of $7.75 (represents a 80.65% upside from PSNL’s last price of $4.29) and a rating consensus of 'Hold', based on 17 wall street analysts offering a 1-year stock forecast.
PSNL Price Target
PSNL Analyst Ratings
Hold
Personalis Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 19, 2024 | Thomas Flaten | Lake Street | $8.00 | $5.91 | 35.36% | 86.48% |
Aug 19, 2024 | Swayampakula Ramakanth | H.C. Wainwright | $9.00 | $5.99 | 50.25% | 109.79% |
Aug 16, 2024 | Mark Massaro | BTIG | $7.00 | $5.99 | 16.86% | 63.17% |
Aug 08, 2024 | Mark Massaro | BTIG | $5.50 | $3.43 | 60.35% | 28.21% |
Aug 08, 2024 | Mike Matson | Needham | $5.50 | $2.88 | 90.97% | 28.21% |
Jun 21, 2024 | Mike Matson | Needham | $3.50 | $1.22 | 186.89% | -18.41% |
Apr 30, 2024 | Thomas Flaten | Loop Capital Markets | $4.00 | $1.47 | 172.11% | -6.76% |
May 06, 2022 | - | Morgan Stanley | $13.00 | $5.16 | 151.94% | 203.03% |
10
Personalis Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 3 | 7 |
Avg Price Target | - | $8.00 | $6.07 |
Last Closing Price | $4.29 | $4.29 | $4.29 |
Upside/Downside | -100.00% | 86.48% | 41.49% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 19, 2024 | Lake Street | Buy | Buy | Hold |
Aug 19, 2024 | BTIG | Underperform | Underperform | Hold |
Aug 19, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 08, 2024 | BTIG | Buy | Buy | Hold |
Aug 08, 2024 | Needham | Buy | Buy | Hold |
Jun 21, 2024 | Needham | Buy | Buy | Hold |
May 09, 2024 | Needham | Buy | Buy | Hold |
May 09, 2024 | Lake Street | Underperform | Underperform | Hold |
Apr 30, 2024 | Lake Street | - | Buy | Initialise |
Feb 24, 2023 | Wedbush | Buy | Buy | Hold |
10
Personalis Financial Forecast
Personalis Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $18.25M | - | $18.86M | $16.72M | $14.86M | $18.24M | $15.23M | $20.68M | $22.26M | $21.67M | $20.88M | $20.18M | $19.82M | $19.50M | $19.16M | $18.15M | $17.15M |
Avg Forecast | $28.21M | $27.77M | $26.07M | $24.55M | $24.66M | $25.46M | $21.06M | $18.54M | $15.54M | $21.33M | $19.27M | $18.37M | $19.63M | $16.98M | $16.49M | $17.35M | $16.72M | $13.99M | $15.51M | $14.34M | $20.52M | $22.24M | $21.21M | $20.43M | $20.02M | $18.99M | $16.33M | $17.20M | $17.91M | $15.77M |
High Forecast | $30.72M | $30.24M | $28.39M | $26.73M | $26.85M | $27.72M | $22.93M | $21.96M | $16.92M | $21.34M | $20.98M | $20.00M | $21.37M | $16.98M | $17.96M | $18.89M | $18.21M | $13.99M | $15.51M | $14.34M | $20.52M | $22.24M | $21.21M | $20.43M | $20.02M | $18.99M | $16.33M | $17.20M | $17.91M | $15.77M |
Low Forecast | $25.91M | $25.50M | $23.95M | $22.54M | $22.64M | $23.38M | $19.34M | $15.10M | $14.27M | $21.32M | $17.69M | $16.87M | $18.03M | $16.98M | $15.15M | $15.93M | $15.36M | $13.99M | $15.51M | $14.34M | $20.52M | $22.24M | $21.21M | $20.43M | $20.02M | $18.99M | $16.33M | $17.20M | $17.91M | $15.77M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | - | 1.09% | 1.00% | 1.06% | 1.18% | 1.06% | 1.01% | 1.00% | 1.02% | 1.02% | 1.01% | 1.04% | 1.19% | 1.11% | 1.01% | 1.09% |
Forecast
Personalis EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-30.79M | - | $-21.93M | $-31.01M | $-24.55M | $-25.66M | $-26.37M | $-18.54M | $-16.09M | $-13.49M | $-10.79M | $-11.77M | $-7.96M | $-7.59M | $-7.71M | $-4.70M | $-5.49M |
Avg Forecast | $-19.20M | $-18.90M | $-17.74M | $-16.70M | $-16.78M | $-17.32M | $-14.33M | $-12.61M | $-10.58M | $-14.52M | $-13.11M | $-38.56M | $-13.36M | $-11.55M | $-11.22M | $-30.48M | $-22.44M | $-9.94M | $-11.02M | $-24.10M | $-14.58M | $-15.80M | $-15.07M | $-12.89M | $-14.23M | $-13.49M | $-11.60M | $-6.48M | $-12.73M | $-11.20M |
High Forecast | $-17.63M | $-17.35M | $-16.29M | $-15.34M | $-15.41M | $-15.91M | $-13.16M | $-10.28M | $-9.71M | $-14.51M | $-12.04M | $-30.85M | $-12.27M | $-11.55M | $-10.31M | $-24.38M | $-17.95M | $-9.94M | $-11.02M | $-19.28M | $-14.58M | $-15.80M | $-15.07M | $-10.31M | $-14.23M | $-13.49M | $-11.60M | $-5.18M | $-12.73M | $-11.20M |
Low Forecast | $-20.91M | $-20.58M | $-19.32M | $-18.19M | $-18.27M | $-18.86M | $-15.60M | $-14.95M | $-11.52M | $-14.52M | $-14.28M | $-46.27M | $-14.54M | $-11.55M | $-12.22M | $-36.58M | $-26.92M | $-9.94M | $-11.02M | $-28.91M | $-14.58M | $-15.80M | $-15.07M | $-15.46M | $-14.23M | $-13.49M | $-11.60M | $-7.77M | $-12.73M | $-11.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.67% | - | 0.72% | 1.38% | 2.47% | 2.33% | 1.09% | 1.27% | 1.02% | 0.90% | 0.84% | 0.83% | 0.59% | 0.65% | 1.19% | 0.37% | 0.49% |
Forecast
Personalis Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-29.10M | - | $-28.66M | $-31.07M | $-26.49M | $-27.55M | $-28.21M | $-20.20M | $-17.67M | $-14.95M | $-12.40M | $-13.34M | $-9.54M | $-9.26M | $-9.14M | $-6.64M | $-6.88M |
Avg Forecast | $-15.24M | $-15.28M | $-16.67M | $-17.12M | $-15.51M | $-17.34M | $-18.19M | $-18.44M | $-18.52M | $-21.37M | $-22.79M | $-41.25M | $-30.53M | $-31.68M | $-32.74M | $-32.61M | $-24.44M | $-32.73M | $-30.56M | $-25.78M | $-26.01M | $-22.19M | $-20.33M | $-14.82M | $-14.96M | $-14.52M | $-17.81M | $-7.68M | $-13.23M | $-12.97M |
High Forecast | $-13.62M | $-13.66M | $-14.90M | $-15.31M | $-13.86M | $-15.50M | $-16.26M | $-12.91M | $-13.58M | $-19.10M | $-20.38M | $-33.00M | $-24.77M | $-28.32M | $-29.27M | $-26.09M | $-19.55M | $-32.73M | $-30.56M | $-20.62M | $-26.01M | $-22.19M | $-20.33M | $-11.85M | $-14.96M | $-14.52M | $-17.81M | $-6.14M | $-13.23M | $-12.97M |
Low Forecast | $-17.00M | $-17.05M | $-18.60M | $-19.10M | $-17.30M | $-19.34M | $-20.30M | $-23.35M | $-23.46M | $-23.84M | $-25.43M | $-49.50M | $-36.29M | $-35.34M | $-36.53M | $-39.13M | $-29.33M | $-32.73M | $-30.56M | $-30.93M | $-26.01M | $-22.19M | $-20.33M | $-17.78M | $-14.96M | $-14.52M | $-17.81M | $-9.21M | $-13.23M | $-12.97M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | - | 0.88% | 1.27% | 0.81% | 0.90% | 1.09% | 0.78% | 0.80% | 0.74% | 0.84% | 0.89% | 0.66% | 0.52% | 1.19% | 0.50% | 0.53% |
Forecast
Personalis SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.97M | - | $14.10M | $17.83M | $14.78M | $15.87M | $15.49M | $13.71M | $12.14M | $11.43M | $10.42M | $10.92M | $7.79M | $7.71M | $7.27M | $6.39M | $6.06M |
Avg Forecast | $16.84M | $16.58M | $15.57M | $14.65M | $14.72M | $15.20M | $12.57M | $11.07M | $9.28M | $12.73M | $11.50M | $10.97M | $11.72M | $10.14M | $9.85M | $10.36M | $16.59M | $8.35M | $9.26M | $14.15M | $12.25M | $13.28M | $12.66M | $12.45M | $11.95M | $11.34M | $9.75M | $6.11M | $10.69M | $9.41M |
High Forecast | $18.34M | $18.05M | $16.95M | $15.96M | $16.03M | $16.55M | $13.69M | $13.11M | $10.10M | $12.74M | $12.52M | $11.94M | $12.76M | $10.14M | $10.72M | $11.28M | $19.91M | $8.35M | $9.26M | $16.98M | $12.25M | $13.28M | $12.66M | $14.94M | $11.95M | $11.34M | $9.75M | $7.33M | $10.69M | $9.41M |
Low Forecast | $15.47M | $15.23M | $14.30M | $13.46M | $13.52M | $13.96M | $11.55M | $9.01M | $8.52M | $12.73M | $10.56M | $10.07M | $10.76M | $10.14M | $9.04M | $9.51M | $13.27M | $8.35M | $9.26M | $11.32M | $12.25M | $13.28M | $12.66M | $9.96M | $11.95M | $11.34M | $9.75M | $4.89M | $10.69M | $9.41M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.18% | - | 1.36% | 1.07% | 1.77% | 1.71% | 1.09% | 1.12% | 0.91% | 0.90% | 0.84% | 0.91% | 0.69% | 0.79% | 1.19% | 0.60% | 0.64% |
Forecast
Personalis EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.60 | - | $-0.61 | $-0.67 | $-0.58 | $-0.60 | $-0.63 | $-0.45 | $-0.40 | $-0.34 | $-0.29 | $-0.38 | $-0.27 | $-0.29 | $-0.29 | $-0.21 | $-0.22 |
Avg Forecast | $-0.25 | $-0.25 | $-0.27 | $-0.28 | $-0.25 | $-0.28 | $-0.30 | $-0.30 | $-0.30 | $-0.35 | $-0.37 | $-0.41 | $-0.50 | $-0.52 | $-0.54 | $-0.58 | $-0.65 | $-0.62 | $-0.58 | $-0.58 | $-0.50 | $-0.42 | $-0.39 | $-0.36 | $-0.29 | $-0.28 | $-0.34 | $-0.26 | $-0.25 | $-0.25 |
High Forecast | $-0.22 | $-0.22 | $-0.24 | $-0.25 | $-0.23 | $-0.25 | $-0.27 | $-0.21 | $-0.22 | $-0.31 | $-0.33 | $-0.36 | $-0.41 | $-0.46 | $-0.48 | $-0.52 | $-0.58 | $-0.62 | $-0.58 | $-0.58 | $-0.50 | $-0.42 | $-0.39 | $-0.36 | $-0.29 | $-0.28 | $-0.34 | $-0.26 | $-0.25 | $-0.25 |
Low Forecast | $-0.28 | $-0.28 | $-0.30 | $-0.31 | $-0.28 | $-0.32 | $-0.33 | $-0.38 | $-0.38 | $-0.39 | $-0.42 | $-0.45 | $-0.59 | $-0.58 | $-0.60 | $-0.65 | $-0.72 | $-0.62 | $-0.58 | $-0.58 | $-0.50 | $-0.42 | $-0.39 | $-0.36 | $-0.29 | $-0.28 | $-0.34 | $-0.26 | $-0.25 | $-0.25 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | - | 1.05% | 1.04% | 0.93% | 1.03% | 1.09% | 0.91% | 0.94% | 0.88% | 0.81% | 1.32% | 0.97% | 0.85% | 1.14% | 0.83% | 0.89% |
Forecast
Personalis Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
DRIO | DarioHealth | $0.81 | $10.75 | 1227.16% | Buy |
STIM | Neuronetics | $0.79 | $8.00 | 912.66% | Buy |
GTH | Genetron | $4.03 | $10.00 | 148.14% | - |
GH | Guardant Health | $30.21 | $57.27 | 89.57% | Buy |
MYGN | Myriad Genetics | $15.68 | $29.00 | 84.95% | Hold |
PSNL | Personalis | $4.30 | $7.75 | 80.23% | Hold |
CRL | Charles River Laboratories | $196.90 | $303.60 | 54.19% | Buy |
ILMN | Illumina | $142.24 | $202.44 | 42.32% | Buy |
CDNA | CareDx | $21.55 | $29.75 | 38.05% | Buy |
CSTL | Castle Biosciences | $30.83 | $40.50 | 31.37% | Buy |
TWST | Twist Bioscience | $38.96 | $42.40 | 8.83% | Buy |
NTRA | Natera | $151.11 | $120.92 | -19.98% | Buy |